Genomenon and Amicus Team Up to Enhance Awareness and Diagnosis of Fabry Disease Genomenon collaborates with Amicus Therapeutics to improve the awareness, diagnosis, and research of Fabry disease by expanding genetic variant data.

Genomenon and Amicus Team Up to Enhance Awareness and Diagnosis of Fabry Disease #United_States #Ann_Arbor #Fabry_disease #Genomenon #Amicus_Therapeutics

Protalix BioTherapeutics Unveils Strong Financial Growth and Ambitious Clinical Developments for FY 2024 Protalix BioTherapeutics has reported impressive revenue growth for fiscal year 2024, alongside promising advancements in clinical trials for gout medications. The company aims to initiate a phase II trial soon.

Protalix BioTherapeutics Unveils Strong Financial Growth and Ambitious Clinical Developments for FY 2024 #Israel #Protalix_BioTherapeutics #Carmiel #PRX-115 #Fabry_disease